Takeda revealed on Wednesday that it is thinking to obtain Shire, which led to rise in its share by 25 percent. It also revealed that there has been no approach made to Shire’s board and the proposal is at a “preparatory and exploratory” stage. No information about the investment was revealed by the Japanese drug makers. Takeda after acquiring Shire will flourish in the market of therapeutic areas of oncology, gastrointestinal disorders and neuroscience. The acquisition of Shire’s rare-disease franchise will give an upper hand to Takeda and will pace up its path to become the pioneer in specialised medicine. This will be also profitable to the Shire as this would increase Shire market opportunities in the US. According to the UK acquisition regulations Takeda should give the final decision about its Shire acquisition by April 25. The other pharma companies such as AbbVie, Novartis, Pfizer will still be the part of the bidding process which might lead to higher pricing in the bidding race.
DelveInsight Blog

Rise In Bispecific Antibodies Utilization ...
Apr 25, 2022
Bispecific Antibodies (BsAbs) are antibodies that contain two different antigens or have two different epitopes on th...

AACR 2022: Novartis shifting focus towards...
Apr 18, 2022
Post Lumakras ‘approval, Adagrasib’s PDUFA date, Novartis now ready to enter the KRASG12C space Novartis is now head...

AACR 2022: LAG-3, one of the most trending...
Apr 14, 2022
Updates on F-star Therapeutics’ and Akeso’s Bi-specific Antibody targeting LAG-3 and PD-L1 F-star Therapeutics presen...
Sign Up and Stay Informed
Penetrative insights and rich analysis of Pharma, Biotech and MedTech space.
Editor's Pick
Commercial Roadmap for the Launch: What can Biopharmaceuticals do to Increase...
The Pharma and Biotech Healthcare market has been an ever-changing industry in terms of...
Emerging Market for Organ on a Chip
The organ on a chip is a microfluidic culture device that recapitulates the complicated...
Global Top Players in Intraocular Lens (IOL) Market
An Intraocular Lens implant is a synthetic, artificial lens placed inside the eye...
Investigating the Pipeline for Ankylosing Spondylitis Treatment Landscape
Ankylosing Spondylitis is a form of arthritis that primarily affects the spine. It caus...
LAG 3: A Promising Next Generation Cancer Immunotherapy
Immunotherapy also called biologic therapy, is a type of cancer treatment that boosts t...
RECENT ARTICLES